Robert Becker
Plus aucun poste en cours
Profil
Robert Becker held several senior director and chief research officer positions in biopharmaceutical development and research & development at Eli Lilly & Co., Biogen, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Aptalis Pharma Srl, Eurand NV, Aptalis Pharma, Inc., Eurand, Inc., TA SASU, and Aptalis Holdings, Inc. He earned a doctorate degree from Technische Universität München.
Anciens postes connus de Robert Becker
| Sociétés | Poste | Fin |
|---|---|---|
TA SASU
 TA SASU Pharmaceuticals: MajorHealth Technology Aptalis Pharma SAS is engaged in manufacturing pharmaceutical preparations. Its products include zenpep, canasa, carafate, pylera, rectiv, viokace, ultresa lacteol, delursan, panzytrat and salofalk. The company was founded in 1982 and is headquartered in Courbevoie, France. | Directeur Technique/Scientifique/R&D | - |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Directeur Technique/Scientifique/R&D | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Aptalis Pharma Srl
 Aptalis Pharma Srl Pharmaceuticals: MajorHealth Technology Aptalis Pharma SRL develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. It offers drug delivery technologies, such as controlling drug release, enhanced bioavailability, dosage form technology and drug conjugation. The company was founded in 1969 and is headquartered in Milan, Italy. | Directeur/Membre du Conseil | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Robert Becker
| Technische Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Eurand NV
 Eurand NV Pharmaceuticals: MajorHealth Technology Eurand NV develops pharmaceutical and biopharmaceutical products using proprietary drug formulation technologies. The company was founded in 1984 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Eurand, Inc.
 Eurand, Inc. Pharmaceuticals: MajorHealth Technology Eurand, Inc. develops pharmaceutical and biopharmaceutical products based on its proprietary drug delivery technologies. The company has had three products approved by the FDA since 2000. The company's most advanced development product, a treatment for exocrine pancreatic insufficiency associated with cystic fibrosis and other diseases, is currently undergoing Phase III clinical trials in the United States. It's technology platforms include: bioavailability enhancement of poorly soluble drugs, customized release, taste masking/fast dissolving formulations and drug conjugation. The company was founded in 1969 and is headquartered in Vandalia, OH. | Health Technology |
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Health Technology |
Aptalis Pharma Srl
Aptalis Pharma Srl Pharmaceuticals: MajorHealth Technology Aptalis Pharma SRL develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. It offers drug delivery technologies, such as controlling drug release, enhanced bioavailability, dosage form technology and drug conjugation. The company was founded in 1969 and is headquartered in Milan, Italy. | Health Technology |
TA SASU
TA SASU Pharmaceuticals: MajorHealth Technology Aptalis Pharma SAS is engaged in manufacturing pharmaceutical preparations. Its products include zenpep, canasa, carafate, pylera, rectiv, viokace, ultresa lacteol, delursan, panzytrat and salofalk. The company was founded in 1982 and is headquartered in Courbevoie, France. | Health Technology |
Aptalis Holdings, Inc.
Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Health Technology |